Potential Implications in Research Tissue and Regenerative Research Researchers hypothesize that IGF-1 LR3 may play a significant role in tissue regeneration due to its proposed impact on cellular proliferation and differentiation
For individuals taking glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity), or the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound), maintaining adequate magnesium status may be particularly important
Stimulants Side effects of stimulants may include: Increased blood pressure and heart rate Insomnia (trouble sleeping) Nervousness Blurred vision Restlessness Headache Some forms may cause constipation, dry mouth, nausea or vomiting
Pregnancy and breastfeeding should be considered absolute contraindications due to unknown effects on fetal development
Insurance Coverage and Payment Options Insurance coverage for weight management semaglutide varies significantly among Philadelphia-area plans
Caution is warranted when: Weight is stable but distress is high Fatigue, hormonal symptoms, or GI issues are the main concern Under-eating or nutrient deficiency is already present Muscle and bone mass are low, or frailty risk is high There is sarcopenia risk, especially in older adults BMI is in the normal range and use would be off-label without a clear medical rationale In these cases, building nutrition adequacy and strength first may improve symptoms and long-term health more than appetite suppression